Tag: BIO TECH

Leading regenerative medicine company, BioStem Technologies (OTC: BSEM) has reported record revenues for the fourth quarter of 2023, reaching $11.5 million, a 1,355% increase year-over-year…. [Read More]

IceCure Medical Ltd. (Nasdaq: ICCM) has filed a 510(k) submission with the FDA for clearance of its next-generation single probe cryoablation system, the XSense™ System… [Read More]

Metabolic therapeutics company, Fractyl Health (Nasdaq: GUTS) has received FDA approval of a pivotal Investigational Device Exemption (IDE) to study its lead product candidate, Revita’s,… [Read More]

Innovent Biologics (HKEX: 01801) has dosed the first participant with IBI310 in combination with sintilimab in a randomized, controlled, multicenter Phase 3 clinical trial for… [Read More]

Molecular genetics diagnostics company, Mainz Biomed N.V. (Nasdaq: MYNZ) presented its ColoAlert® cancer screening innovation at the 39th UDH Congress in Fellbach, Germany this month…. [Read More]

Psychedelic-based therapeutics company, Cybin, Inc. (NYSE American: CYBN) has achieved an impressive number of key milestones this month, and the investment community is taking note…. [Read More]

NeuroOne Medical Technologies (Nasdaq: NMTC) has initiated a limited commercial launch of its OneRF™ Ablation System, a stereoelectroencephalogram (sEEG)-guided tool used in neurosurgery to record… [Read More]

Enveric Biosciences (Nasdaq: ENVB) has provided a corporate update and reported financial results for the fourth quarter of 2023 and fiscal year ended December 31,… [Read More]

Shares in Viking Therapeutics (Nasdaq: VKTX) surged on Tuesday after the company announced positive results from its Phase 1 clinical trial evaluating its oral tablet… [Read More]

 Medical technology company, Neuronetics, Inc. (Nasdaq: STIM), has received clearance from the FDA for its NeuroStar Advanced Therapy for use as an adjunct for the… [Read More]